Sign Up Today and Learn More About Alkeus Pharmaceuticals Stock
Invest in or calculate the value of your shares in Alkeus Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Alkeus Pharmaceuticals Stock (ALKP)
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
About Alkeus Pharmaceuticals Stock
Founded
2011
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
Alkeus Pharmaceuticals Press Mentions
Stay in the know about the latest news on Alkeus Pharmaceuticals
Age-related Macular Degeneration Market Report 2025-2030 - Asia-Pacific and EMEA Fuel Growth in AMD Market with Reforms and Expanding Access to Vision Care
globenewswire • Apr 08, 2025
Alkeus Pharmaceuticals Establishs Scientific Board
citybiz • Feb 26, 2025
Alkeus Pharmaceuticals Announces Two Presentations of Oral Gildeuretinol Data During the 48th Annual Meeting of the Macula Society Being Held February 12-15, 2025
biospace • Feb 11, 2025
70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight
prnewswire • Jan 23, 2025
Alkeus Pharmaceuticals Announces New Positive Interim TEASE-3 Study Results Showing Gildeuretinol Prevented Disease Progression in Early-Stage Stargardt Patients
biospace • Jan 10, 2025
Alkeus Pharmaceuticals Management
Leadership team at Alkeus Pharmaceuticals
President and Chief Executive Officer
Leonide Saad
Co-Founder
Ilyas Washington
Join now and verify your accreditation status to gain access to:
- Alkeus Pharmaceuticals Current Valuation
- Alkeus Pharmaceuticals Stock Price
- Alkeus Pharmaceuticals Management
- Available deals in Alkeus Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Alkeus Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Alkeus Pharmaceuticals Revenue and Financials
- Alkeus Pharmaceuticals Highlights
- Alkeus Pharmaceuticals Business Model
- Alkeus Pharmaceuticals Risk Factors
- Alkeus Pharmaceuticals Research Report from SACRA Research
Trading Alkeus Pharmaceuticals Stock
How to invest in Alkeus Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Alkeus Pharmaceuticals through EquityZen funds. These investments are made available by existing Alkeus Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alkeus Pharmaceuticals stock?
Shareholders can sell their Alkeus Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
